AstraZeneca has announced that its vaccine candidate has shown an average efficacy of about 70% , The vaccine candidate has been developed along with the Oxford. The potential vaccine against the novel coronavirus maybe around 90 percent effective, the company said citing interim analysis of results from late-stage clinical trials.

Oxford-AstraZeneca says COVID-19 vaccine candidate is 70% effective

vaccine-candidate

Vaccine Candidate, News on Vaccine Candidate, stories on Vaccine Candidate, articles on Vaccine Candidate, Vaccine Candidate stories at Wion, Vaccine Candidate news, Vaccine Candidate latest news